000 | 00993 a2200289 4500 | ||
---|---|---|---|
005 | 20250513160401.0 | ||
264 | 0 | _c19981204 | |
008 | 199812s 0 0 eng d | ||
022 | _a0028-4793 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNathan, D G | |
245 | 0 | 0 |
_aIron chelation with oral deferiprone in patients with thalassemia. _h[electronic resource] |
260 |
_bThe New England journal of medicine _cDec 1998 |
||
300 |
_a1711-2; author reply 1713-4 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 | _aDeferiprone |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIron Chelating Agents _xadverse effects |
650 | 0 | 4 |
_aIron Overload _xdrug therapy |
650 | 0 | 4 |
_aLiver _xpathology |
650 | 0 | 4 |
_aLiver Cirrhosis _xetiology |
650 | 0 | 4 |
_aPyridones _xadverse effects |
650 | 0 | 4 |
_abeta-Thalassemia _xpathology |
700 | 1 | _aWeatherall, D J | |
773 | 0 |
_tThe New England journal of medicine _gvol. 339 _gno. 23 _gp. 1711-2; author reply 1713-4 |
|
999 |
_c9830298 _d9830298 |